Complex chromosome 4, 9, and 22 rearrangement in a patient presenting with AML-FAB M2

• Published in: Cancer genetics and cytogenetics 1997-02, Vol.93 (2), p.119-124
• Main Authors: Martin, E.S., Joseph, A., Ahmad, M.A., Borgaonkar, D.S., Martin, S.E.
• Format: Article
• Language: English
• Subjects: Adult; Antigens, CD - analysis; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biological and medical sciences; Bone Marrow Transplantation; Chromosomes, Human, Pair 22 - genetics; Chromosomes, Human, Pair 4 - genetics; Chromosomes, Human, Pair 9 - genetics; Combined Modality Therapy; Fusion Proteins, bcr-abl - analysis; Hematologic and hematopoietic diseases; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute - genetics; Leukemia, Myeloid, Acute - immunology; Leukemia, Myeloid, Acute - therapy; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Male; Medical sciences; Philadelphia Chromosome; Translocation, Genetic - genetics
• ISSN: 0165-4608; 1873-4456
• DOI: 10.1016/S0165-4608(96)00187-2

Fluorescence in situ hybridization (FISH) and the reverse transcription-polymerase chain reaction (RT-PCR) were used to examine a patient presenting with acute myelogenous leukemia (AML) FAB M2, and a complex t(4;9;22)(p14;q34;q11.2). The patient's clinical course was characterized by an aggressive leukemia, resistant to intensive therapy including allogeneic bone marrow transplantation. FISH analysis, using two chromosome painting probes and a BCR/ABL specific probe, confirmed the cytogenetic observation of a 22q11.2→4p14 and a 4p14→9q34 exchange, and revealed the presence of a 9q34→22q11.2, respectively. In addition, RT-PCR demonstrated the presence of a BCR/ABL transcript derived from the major breakpoint cluster region (M-bcr) of the BCR gene. This transcript has been shown to generate an active 210 kDa tyrosine kinase protein more commonly observed in chronic myelogenous leukemia. Because the presentation of AML with this ABL→BCR fusion product is a rare event, it would seem likely that the additional complex chromosomal rearrangement involving chromosomes 4, 9, and 22 played a role in the aggressive presentation and clinical behavior of this patient's leukemia.